What is HCPCS code C9165?

C9165 is the HCPCS Level II code for Injection, elranatamab-bcmm, 1 mg. It falls in Section C (Outpatient PPS (Hospital)) of the 2026 HCPCS Level II code set maintained by CMS.

Is C9165 covered by Medicare?

Medicare coverage status for C9165 is: Special coverage instructions apply. Always confirm current coverage with the payer.

Under Medicare Part B, C9165 is priced as: Statute.

C9165 Injection, elranatamab-bcmm, 1 mg

Short descriptor: Inj, elranatamab-bcmm, 1 mg

⚠ Terminated HCPCS Level II 2026

Terminated Code

C9165 was terminated as of 2024-03-31 and should not be reported for dates of service after that date. This page is retained for historical reference.

Open C9165 in the app →

Look up C9165 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9165 is the HCPCS Level II code for Injection, elranatamab-bcmm, 1 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Section: C: Outpatient PPS (Hospital)
Medicare Coverage: Special coverage instructions apply (code D)
Part B Pricing: Statute (indicator 53)
Type of Service: Medical care
Effective Date: 2024-04-01
Termination Date: 2024-03-31
2026 Maintenance: No change this year

References

Cite This Page

Reference C9165 with the canonical source and edition:

C9165 — Injection, elranatamab-bcmm, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9165

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9165

C9165 Injection, elranatamab-bcmm, 1 mg

Classification & CMS Attributes

References

Cite This Page

Related Codes in Section C

Get HCC Mappings, Clinical Summaries, and More